These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15071372)

  • 1. Alternative and/or integrative therapies for pneumonia under development.
    Cazzola M; Page CP; Matera MG
    Curr Opin Pulm Med; 2004 May; 10(3):204-10. PubMed ID: 15071372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation--a new therapeutic target in pneumonia.
    Cazzola M; Matera MG; Pezzuto G
    Respiration; 2005; 72(2):117-26. PubMed ID: 15824518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of endotoxin release and cytokine production induced by antibiotics in patients with Gram-negative nosocomial pneumonia.
    Maskin B; Fontán PA; Spinedi EG; Gammella D; Badolati A
    Crit Care Med; 2002 Feb; 30(2):349-54. PubMed ID: 11889308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor.
    Weiss CA; Wasiluk KR; Kellogg TA; Dunn DL
    Surgery; 2000 Aug; 128(2):339-44. PubMed ID: 10923014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions.
    Opal SM; Yu RL
    Drugs; 1998 Apr; 55(4):497-508. PubMed ID: 9561340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides with dual mode of action: Killing bacteria and preventing endotoxin-induced sepsis.
    Brandenburg K; Heinbockel L; Correa W; Lohner K
    Biochim Biophys Acta; 2016 May; 1858(5):971-9. PubMed ID: 26801369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cethromycin: a promising new ketolide antibiotic for respiratory infections.
    Rafie S; MacDougall C; James CL
    Pharmacotherapy; 2010 Mar; 30(3):290-303. PubMed ID: 20180612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotoxin-binding and -neutralizing properties of recombinant bactericidal/permeability-increasing protein and monoclonal antibodies HA-1A and E5.
    Marra MN; Thornton MB; Snable JL; Wilde CG; Scott RW
    Crit Care Med; 1994 Apr; 22(4):559-65. PubMed ID: 8143464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of antimicrobial and endotoxin-neutralizing activities of novel oleoylamines.
    Zorko M; Majerle A; Sarlah D; Keber MM; Mohar B; Jerala R
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2307-13. PubMed ID: 15917526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An experimental analysis of the curative action of penicillin in acute bacterial infections. III. The effect of suppuration upon the antibacterial action of the drug.
    SMITH MR; WOOD WB
    J Exp Med; 1956 Apr; 103(4):509-22. PubMed ID: 13306859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel approaches to the treatment of pneumonia.
    Cazzola M; Matera MG; Page CP
    Trends Pharmacol Sci; 2003 Jun; 24(6):306-14. PubMed ID: 12823957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial Agents And Resistance--Fifth International Symposium.
    Jacobs MR
    IDrugs; 2005 Jul; 8(7):542-6. PubMed ID: 15973559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New therapies for pneumonia.
    Ricard JD
    Curr Opin Pulm Med; 2012 May; 18(3):181-6. PubMed ID: 22388584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo designed lipopolysaccharide binding peptides: structure based development of antiendotoxic and antimicrobial drugs.
    Bhattacharjya S
    Curr Med Chem; 2010; 17(27):3080-93. PubMed ID: 20629624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiadhesion agents against Gram-positive pathogens.
    Cascioferro S; Cusimano MG; Schillaci D
    Future Microbiol; 2014; 9(10):1209-20. PubMed ID: 25405889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gram-negative bacterial pneumonia: aetiology and management.
    Koulenti D; Rello J
    Curr Opin Pulm Med; 2006 May; 12(3):198-204. PubMed ID: 16582675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
    Chockalingam A; Zarlenga DS; Bannerman DD
    Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
    Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oritavancin--an investigational glycopeptide antibiotic.
    Ward KE; Mersfelder TL; LaPlante KL
    Expert Opin Investig Drugs; 2006 Apr; 15(4):417-29. PubMed ID: 16548791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic induced endotoxin release and clinical sepsis: a review.
    Holzheimer RG
    J Chemother; 2001 Nov; 13 Spec No 1(1):159-72. PubMed ID: 11936361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.